CAROL MOSES: Open Payments
NPI 1245892777 · GREENWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 7 payments from 5 companies in 2025. Trend: 2023 $13 · 2024 $20 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $140 |
| Lundbeck LLC | 1 | $31 |
| Novo Nordisk Inc | 1 | $26 |
| ABBVIE INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: AIRSUPRA, REXULTI, Rybelsus, QULIPTA, FARXIGA.
Industry payments across MS — which companies pay providers there.
